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Profile of Peng Li 
 
 
Dr. Peng Li received her B.S. degree from Beijing Normal 
University (China) in 1987. In 1988, she joined the De-
partment of Biochemistry, University of Texas Southwest-
ern Medical Center at Dallas (USA) as a CUSBEA (Chi-
na–United States Biochemistry Examination and Applica-
tion) student. In 1995, she received her Ph.D. degree from 
University of California at San Diego (U.S.A). She then did 
her post-doctoral training in Howard Hughes Medical Insti-
tute, University of Texas Southwestern Medical Center at 
Dallas (U.S.A) and Institute of Molecular and Cell Biology 
(Singapore) between 1996 and 1997. She became assistant 
professor and principal investigator in the Institute of Mo-
lecular and Cell Biology at the end of 1997. She then moved 
to Hong Kong University of Science and Technology in 
2003 and became tenured associate professor in 2005. In 
2006, she moved to the Department of Biological Sciences 
and Biotechnology (current School of Life Sciences), 
Tsinghua University as a professor, and served as the vice 
dean of School of Life Sciences in Tsinghua University 
between 2009 and 2015. She was awarded Changjiang 
Scholar from the Ministry of Education (China) and Out-
standing Young Talent from the National Natural Science 
Foundation of China. Dr. Li is currently a professor of 
School of Life Sciences and senior investigator of Tsing-
hua-Peking Center for Life Sciences in Tsinghua Universi-
ty. She was elected Academician of the Chinese Academy 
of Sciences in 2015. 
Dr. Li’s research interest is in the area of lipid metabo-
lism and the development of metabolic diseases, including 
obesity and fatty liver disease with special focus on the bi-
ogenesis, fusion and growth of lipid droplets. During the 
past many years, Dr. Li has made many outstanding contri-
butions in the area of lipid metabolism. 
Identification of novel family of proteins that con-
trol lipid metabolism and the development of met-
abolic diseases 
Metabolic disorders, including obesity, hyperlipidemia, in-




of diseases associated with metabolic malfunction and un-
balanced energy homeostasis. Dr. Li has pioneered in the 
research of the biological functions and the underlying 
mechanisms in controlling lipid metabolism and the devel-
opment of metabolic disorders for CIDE (cell death-   
inducing DFFA (DNA fragmentation factor, alpha subunit)- 
like effector) family proteins. They have identified CIDE 
family proteins as ER and lipid droplet (LD)-associated 
proteins with highly restricted expression in adipose tissue, 
liver, skin sebocytes and pregnant and lactated mammary 
epithelia cells. By using genetically modified animal models 
and various biochemical and cell biology techniques, she 
and her colleagues have demonstrated that CIDE proteins 
are important regulators in the development of obesity, dia-
betes and liver steatosis by controlling various lipid meta-
bolic pathways including lipid storage, LD fusion and 
growth in adipocytes and hepatocytes, lipid secretion in 
mammary epithelia cells and skin sebocytes, AMPK activity 
and VLDL secretion in hepatocytes (Li et al., 2007; Qi et al., 
2008; Toh et al., 2008; Wang et al., 2012; Ye et al., 2009; 
Zhang et al., 2014; Zhou et al., 2003). Their research also 
suggest that CIDE proteins may serve as potential molecular 
targets for the screening of pharmacological agents for the 
prevention and treatment of metabolic disorders.  
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Delineating the molecular basis of LD fusion and 
growth  
LDs, dynamic cellular organelles present in most eukaryotic 
cells, play important roles not only in controlling lipid stor-
age but also in many biological processes including virus 
packaging, intracellular protein metabolism and trafficking, 
and insulin signaling. However, the molecular components 
that determine biogenesis and growth of LDs as an orga-
nelle are poorly understood. Dr. Li and colleagues have 
demonstrated that CIDE family proteins are specifically 
clustered and enriched at the LD contact site (LDCS) where 
they initiate a unique atypical fusion by promoting lipid 
exchange and lipid transfer from smaller to larger LDs 
(Gong et al., 2011). CIDE-mediated LD fusion and growth  
is essential for the formation of unilocular LD formation 
and maximal lipid storage in adipocytes. It is also important 
in enhancing lipid storage in hepatocytes, mammary epithe-
lia cells and skin sebocytes (Li et al., 2007; Wang et al., 
2012; Zhang et al., 2014). Furthermore, Dr. Li and col-
leagues have identified several other factors and signaling 
circuits that control LD fusion and lipid storage in adipo-
cytes, including Plin1, Rab8a, AS160 and MSS4 (Sun et al., 
2013; Wu et al., 2014). 
Dr. Li has published more than 60 papers on world top 
journals and her research cited more than 9000 times. Her 
original and systematic research has earned her a pioneering 
role and international reputation in the field of lipid metabo-
lism and metabolic diseases. She is the co-editor of the 
volume “Lipid Droplets” in Methods in Cell Biology. She 
has been an invited speaker of many international confer-
ences, including Gordon Research Conference, the FASEB 
Science Research Conference, and the Cold Spring Harbor 
Asia Conference. She has organized many international 
conferences in lipid research and severed as an editorial 
board member of several international journals. Dr. Li is the 
project leader of the Innovative Group Research of the Na-
tional Natural Science Foundation of China for “Lipid Ho-
meostasis and Lipid Droplet”, and the chief scientist of the 
National Basic Research Project on “Regulation of Lipid 
Metabolism and the Physiology and Pathology of Obesity”. 
She has served as the scientific advisory board member of 
the National Natural Science Foundation of China and the 
council member of The Biophysical Society of China. Dr. 
Li has received important awards including Singapore 
Young Scientist award in 1999, the Arthur Kornberg Me-
morial lecture award by A-IMBN in 2008, and Ho Leung 
Ho Lee Foundation prize for Scientific and Technological 
Progress in Life Sciences in 2012.  
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